Don’t blame Big Pharma for insulin’s problems
For diabetics, insulin matters as much as H2O. Unfortunately, insulin’s a hell of a lot more expensive than bottled water. High insulin prices force approximately nine million Americans to balance their wallet and well-being.
The American Action Forum reported that a type-one diabetic’s average yearly expense for insulin was $~6000 (i.e., $500/month). It’s easy to lambast Big Pharma companies for the current state of insulin’s affairs, but history and market behavior …










![Medical brain drain leaves vulnerable communities without life-saving care [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-190x100.jpg)
![Catching type 1 diabetes before it becomes life-threatening [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-2-190x100.jpg)

![Regulatory red tape threatens survival of rare disease patients [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-4-190x100.jpg)

